Lv1
50 积分 2021-09-23 加入
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
1个月前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
5个月前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
10个月前
已完结
Estrogen receptor subtypes and survival outcomes in non-small cell lung cancer
11个月前
已完结
Estrogen, estrogen receptor and the tumor microenvironment of NSCLC
1年前
已完结
皖公网安备34019202002308
